Skip to main content

Advertisement

Table 1 Distribution of incident breast cancer (BC) by country, estrogen receptor (ER) status, and baseline menopausal status among the women from the European Prospective Investigation into Cancer and Nutrition (EPIC) and Women’s Health Initiative (WHI) studies

From: Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts

  Number Age at recruitment (years) Years of follow-up Incident BC Crude incidence rate (/105 person-years) Premenopausal Postmenopausal
ER+ ER- Indefinite BC ER+ ER- Indefinite BC
EPIC study
 France 68,707 51.5 14.7 3386 382 1232 323 221 1776 1150 254 206 1610
 Italy 27,851 52.0 15.0 1135 287 401 88 92 581 402 70 82 554
 Spain 20,298 50.2 16.7 556 171 164 43 92 299 148 38 71 257
 UK 35,349 52.3 16.1 1602 300 328 76 267 671 475 65 391 931
 Netherlands 22,601 54.8 15.0 975 305 206 35 143 384 333 55 203 591
 Greece 11,337 55.6 11.7 201 158 19 6 44 69 35 3 94 132
 Germany 22,085 52.6 11.6 743 322 198 52 49 299 308 73 63 444
 Sweden 9142 50.5 16.4 370 247 143 38 38 219 87 27 37 151
 Denmark 29,309 56.3 16.4 1887 428 257 61 100 418 921 207 341 1469
 Norway 34,651 48.0 14.1 1212 263 245 54 480 779 158 30 245 433
 Total 281,330 52.1 14.7 12,067 312 3193 776 1526 5495 4017 822 1733 6572
WHI study 82,319 63.2 8.2 2951 457 2276 421 254 2951